Company Filing History:
Years Active: 2011
Title: **Innovative Contributions of Lenore A. Herzenberg in HIV Research**
Introduction
Lenore A. Herzenberg is an esteemed inventor based in Stanford, California, who has made significant strides in the field of immunology and HIV research. With a focus on activating peripheral blood mononuclear cells, her patents hold great value in understanding and potentially combating HIV infections.
Latest Patents
Lenore A. Herzenberg's notable patent involves methods for activating peripheral blood mononuclear cells (PBMCs) by administering human immunodeficiency virus (HIV) Tat under physiological oxygen levels. This invention outlines methods that not only activate PBMCs but also aid in the identification of blocking agents that inhibit Tat protein activation. Additionally, it highlights an active portion of a Tat polypeptide for potential use as an immunogen in vaccines. The patent further includes the development of an immunogen comprising an isolated variant of wild-type HIV Tat protein that shows reduced priming of competent cells compared to the original HIV Tat protein. Moreover, a diagnostic kit for identifying blocking agents related to HIV Tat protein is also part of this significant patent.
Career Highlights
Lenore A. Herzenberg has made remarkable contributions to her field through her role at the Board of Trustees of the Leland Stanford Junior University. Her passion for research and innovation has led to the advancement of methods that could potentially change the landscape of HIV treatment and prevention.
Collaborations
Throughout her career, Lenore has collaborated with distinguished professionals, including her coworker Bita Sahaf. Their partnership reflects a commitment to advancing medical research and enhancing the efficacy of treatments for HIV.
Conclusion
Lenore A. Herzenberg's pioneering work in developing methods to activate peripheral blood mononuclear cells has positioned her as a prominent figure in HIV research. Her inventions not only provide valuable insights into the mechanisms of HIV but also pave the way for future innovations in immunology and vaccine development.